Johanna Roberts Sells 300 Shares of Penumbra (NYSE:PEN) Stock

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 300 shares of Penumbra stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average price of $300.13, for a total transaction of $90,039.00. Following the completion of the transaction, the executive vice president owned 63,836 shares in the company, valued at approximately $19,159,098.68. This trade represents a 0.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Johanna Roberts also recently made the following trade(s):

• On Monday, December 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $294.94, for a total value of $176,964.00.
• On Tuesday, November 25th, Johanna Roberts sold 1,800 shares of Penumbra stock. The stock was sold at an average price of $300.06, for a total value of $540,108.00.
• On Monday, November 10th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $266.98, for a total value of $160,188.00.
• On Wednesday, October 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $249.70, for a total value of $149,820.00.

Penumbra Trading Up 5.5%

Shares of PEN opened at $302.89 on Thursday. The business’s 50-day moving average price is $266.75 and its 200 day moving average price is $258.56. The company has a current ratio of 6.73, a quick ratio of 4.18 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $11.86 billion, a P/E ratio of 72.46, a P/E/G ratio of 2.37 and a beta of 0.66. Penumbra, Inc. has a 1-year low of $221.26 and a 1-year high of $310.00.

Penumbra (NYSE:PEN) last announced its earnings results on Wednesday, November 5th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.90 by $0.07. Penumbra had a net margin of 12.30% and a return on equity of 11.35%. The company had revenue of $354.69 million during the quarter, compared to analysts’ expectations of $340.77 million. During the same period last year, the company posted $0.85 earnings per share. The business’s revenue for the quarter was up 17.8% on a year-over-year basis. Analysts expect that Penumbra, Inc. will post 3.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PEN has been the topic of several recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Penumbra in a research note on Monday. BTIG Research reiterated a “buy” rating and set a $320.00 price target on shares of Penumbra in a report on Monday, October 27th. Wall Street Zen lowered Penumbra from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Truist Financial reduced their price objective on Penumbra from $310.00 to $300.00 and set a “buy” rating for the company in a research note on Wednesday, October 15th. Finally, Wells Fargo & Company began coverage on Penumbra in a research note on Tuesday, November 18th. They set an “underweight” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $305.69.

Institutional Trading of Penumbra

A number of institutional investors have recently bought and sold shares of PEN. Allworth Financial LP increased its position in Penumbra by 36.2% in the 3rd quarter. Allworth Financial LP now owns 241 shares of the company’s stock worth $61,000 after purchasing an additional 64 shares during the last quarter. Swiss Life Asset Management Ltd grew its stake in shares of Penumbra by 77.6% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 1,689 shares of the company’s stock valued at $428,000 after buying an additional 738 shares in the last quarter. Danske Bank A S acquired a new position in Penumbra in the third quarter worth approximately $76,000. CANADA LIFE ASSURANCE Co raised its position in Penumbra by 6.4% during the third quarter. CANADA LIFE ASSURANCE Co now owns 28,395 shares of the company’s stock valued at $7,145,000 after acquiring an additional 1,720 shares in the last quarter. Finally, United Capital Financial Advisors LLC acquired a new stake in Penumbra in the third quarter valued at approximately $839,000. Institutional investors and hedge funds own 88.88% of the company’s stock.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.